logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Reboot biomedical R&D in the global public interest

Swaminathan S, Pecoul B, Abdullah H, Christou C, Gray G,  et al.
2022-02-09 • Nature
2022-02-09 • Nature
Journal Article
|
Research

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004

Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA,  et al.
2005-12-01 • Lancet Infectious Diseases
2005-12-01 • Lancet Infectious Diseases
The state of Bihar in India carries the largest share of the world's burden of antimony-resistant visceral leishmaniasis. We analysed clinical studies done in Bihar with different treatm...
Journal Article
|
Research

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea

Boum Y II, Juan-Giner A, Hitchings MD, Soumah A, Strecker T,  et al.
2020-06-01 • Vaccine
2020-06-01 • Vaccine
Background
As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional inf...
Journal Article
|
Commentary

A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Balsegaram M, Brechot C, Farrar J, Heymann D, Ganguly N,  et al.
2015-05-11 • PLOS Medicine
2015-05-11 • PLOS Medicine
Bernard Pécoul and colleagues call for the establishment of a global biomedical R&D fund as a key priority of the G7 summit in June 2015.
Journal Article
|
Commentary

Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

Mendelson M, Rottingen JA, Gopinathan U, Hamer DH, Wertheim H,  et al.
2015-11-18 • Lancet
2015-11-18 • Lancet
Journal Article
|
Research

Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results from the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!)

Henao-Restrepo AM, Camacho A, Longini I, Watson CH, Edmunds WJ,  et al.
2017-02-01 • Lancet
2017-02-01 • Lancet
BACKGROUND
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the ...
Journal Article
|
Commentary

Strategies for achieving global collective action on antimicrobial resistance

Hoffman SJ, Caleo GNC, Daulaire N, Elbe S, Matsoso P,  et al.
2015-12-01 • Bulletin of the World Health Organization
2015-12-01 • Bulletin of the World Health Organization
Global governance and market failures mean that it is not possible to ensure access to antimicrobial medicines of sustainable effectiveness. Many people work to overcome these failures, ...
Journal Article
|
Commentary

Diagnostic preparedness for infectious disease outbreaks

Perkins MD, Dye C, Balasegaram M, Brechot C, Mombouli JV,  et al.
2017-11-11 • Lancet
2017-11-11 • Lancet
Diagnostics are crucial in mitigating the effect of disease outbreaks. Because diagnostic development and validation are time consuming, they should be carried out in anticipation of epi...